We have located links that may give you full text access.
Prognostic Value of Cardiac Troponin I and L-Lactate in Blood of Dairy Cows Affected by Downer Cow Syndrome.
Journal of Veterinary Internal Medicine 2018 January
BACKGROUND: The downer cow syndrome (DCS) is a challenging health issue in the dairy industry. No cow-side test is available to provide an accurate prognosis for DCS cases in farm settings.
HYPOTHESIS/OBJECTIVES: Local or systemic hypoperfusion and myocardial lesions lead to an increase in blood concentration of biomarkers cardiac troponin I (cTnI) and L-lactate. The objective was to determine the prognostic values of these biomarkers assessed cow-sides in addition to clinical examinations in prognostication of a negative outcome (NO: death or euthanasia within 7 days).
ANIMALS: 218 client-owned dairy cows affected by DCS.
METHODS: In a prospective study, animals were monitored for 60 days after inclusion of each cow. Blood cTnI and L-lactate concentrations were measured on the day of inclusion. The prognostic accuracy of both biomarkers and physical examination variables was estimated to predict NO. A mixed multivariable logistic regression model was used for data analysis.
RESULTS: Prevalence of NO in this study was 63% on day 7. Troponin concentrations greater than 0.7 ng/mL had sensitivity and specificity of 54.1% (95% CI: 45.3-62.7%) and 78.4% (95% CI: 67.3-87.1%), respectively, for predicting NO. Blood L-lactate was not associated with the outcome. The multivariable model revealed that heart rate >100 bpm (OR; 95% CI: 3.7; 1.3-10.2) and cTnI > 0.7 ng/mL (OR; 95% CI: 5.5; 2.1-14.6) were associated with the risk of NO.
CONCLUSIONS AND CLINICAL IMPORTANCE: Hypertroponinemia and tachycardia were associated with reduced survival in DCS cases. The use of cow-side blood cTnI concentrations and heart rate could help to rapidly identify cows in farm setting that have poor chances of recovery and would benefit from a more aggressive treatment or euthanasia.
HYPOTHESIS/OBJECTIVES: Local or systemic hypoperfusion and myocardial lesions lead to an increase in blood concentration of biomarkers cardiac troponin I (cTnI) and L-lactate. The objective was to determine the prognostic values of these biomarkers assessed cow-sides in addition to clinical examinations in prognostication of a negative outcome (NO: death or euthanasia within 7 days).
ANIMALS: 218 client-owned dairy cows affected by DCS.
METHODS: In a prospective study, animals were monitored for 60 days after inclusion of each cow. Blood cTnI and L-lactate concentrations were measured on the day of inclusion. The prognostic accuracy of both biomarkers and physical examination variables was estimated to predict NO. A mixed multivariable logistic regression model was used for data analysis.
RESULTS: Prevalence of NO in this study was 63% on day 7. Troponin concentrations greater than 0.7 ng/mL had sensitivity and specificity of 54.1% (95% CI: 45.3-62.7%) and 78.4% (95% CI: 67.3-87.1%), respectively, for predicting NO. Blood L-lactate was not associated with the outcome. The multivariable model revealed that heart rate >100 bpm (OR; 95% CI: 3.7; 1.3-10.2) and cTnI > 0.7 ng/mL (OR; 95% CI: 5.5; 2.1-14.6) were associated with the risk of NO.
CONCLUSIONS AND CLINICAL IMPORTANCE: Hypertroponinemia and tachycardia were associated with reduced survival in DCS cases. The use of cow-side blood cTnI concentrations and heart rate could help to rapidly identify cows in farm setting that have poor chances of recovery and would benefit from a more aggressive treatment or euthanasia.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app